Epinephrine Dosing for Anaphylaxis
For anaphylaxis, administer epinephrine intramuscularly at a dose of 0.3-0.5 mg (0.3-0.5 mL of 1:1000 concentration) for adults and children ≥30 kg, or 0.01 mg/kg (maximum 0.3 mg) for children <30 kg, injected into the anterolateral aspect of the mid-thigh. 1, 2
Dosing Guidelines
Adults and Children ≥30 kg (66 lbs):
- Dose: 0.3-0.5 mg
- Concentration: 1:1000 (1 mg/mL)
- Volume: 0.3-0.5 mL
- Route: Intramuscular (IM) injection into anterolateral thigh
- Frequency: Can be repeated every 5-10 minutes as necessary 1, 2
Children <30 kg (66 lbs):
- Dose: 0.01 mg/kg (maximum 0.3 mg)
- Concentration: 1:1000 (1 mg/mL)
- Volume: 0.01 mL/kg (maximum 0.3 mL)
- Route: Intramuscular (IM) injection into anterolateral thigh
- Frequency: Can be repeated every 5-10 minutes as necessary 1, 2
Administration Route
- The intramuscular route in the anterolateral thigh is preferred for initial treatment due to:
Alternative Routes in Special Circumstances
Intravenous Administration
- When an IV line is already in place and the patient is in anaphylactic shock, IV epinephrine may be considered
- IV dose: 0.05 to 0.1 mg (5-10% of the cardiac arrest dose)
- Concentration: 0.1 mg/mL (1:10,000) 4
Continuous Infusion
- For persistent anaphylactic shock or recurrence of symptoms
- IV infusion at 5-15 μg/min
- Allows for careful titration and avoidance of overdosing 4
Important Clinical Considerations
Timing of Administration
- Administer immediately upon recognition of anaphylaxis
- Delays in administration may be fatal
- No absolute contraindications for epinephrine use in anaphylaxis 1, 3, 5
Special Populations
- Elderly patients and those with cardiac disease, hyperthyroidism, Parkinson's disease, diabetes, or pheochromocytoma require caution but should still receive epinephrine for anaphylaxis 1
Common Pitfalls to Avoid
- Incorrect route selection: Avoid injecting into buttocks, digits, hands, or feet 2
- Delayed administration: Failure to promptly administer epinephrine is associated with increased mortality 3
- Incorrect dose calculation: Studies show many healthcare providers are unfamiliar with correct dosing 6, 7
- Inappropriate needle length: Standard auto-injector needles may be too short for obese patients or too long for small children 8
- Confusion with cardiac arrest dosing: The anaphylaxis dose is different from cardiac arrest dosing 6
Monitoring and Follow-up
- Observe patients for at least 4-6 hours after symptom resolution
- Extended observation (8-24 hours) for severe reactions or those requiring multiple epinephrine doses
- Monitor vital signs including blood pressure, heart rate, and oxygen saturation 1
Remember that epinephrine is the cornerstone of anaphylaxis management, and prompt administration can be life-saving. The intramuscular route in the anterolateral thigh provides the optimal balance of rapid absorption and safety.